BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28083701)

  • 1. Disorders of fatty acid oxidation and autosomal recessive polycystic kidney disease-different clinical entities and comparable perinatal renal abnormalities.
    Hackl A; Mehler K; Gottschalk I; Vierzig A; Eydam M; Hauke J; Beck BB; Liebau MC; Ensenauer R; Weber LT; Habbig S
    Pediatr Nephrol; 2017 May; 32(5):791-800. PubMed ID: 28083701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal ultrasound, genotype, and outcome in a large cohort of prenatally affected patients with autosomal-recessive polycystic kidney disease and other hereditary cystic kidney diseases.
    Erger F; Brüchle NO; Gembruch U; Zerres K
    Arch Gynecol Obstet; 2017 Apr; 295(4):897-906. PubMed ID: 28283827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel electron transfer flavoprotein dehydrogenase (ETFDH) gene mutation identified in a newborn with glutaric acidemia type II: a case report of a Chinese family.
    Ou M; Zhu L; Zhang Y; Zhang Y; Zhou J; Zhang Y; Chen X; Yang L; Li T; Su X; Hu Q; Wang W
    BMC Med Genet; 2020 May; 21(1):98. PubMed ID: 32393189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal ultrasonography of autosomal dominant polycystic kidney disease mimicking recessive type: case series.
    Garel J; Lefebvre M; Cassart M; Della Valle V; Guilbaud L; Jouannic JM; Ducou le Pointe H; Blondiaux E; Garel C
    Pediatr Radiol; 2019 Jun; 49(7):906-912. PubMed ID: 30631912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal sonographic diagnosis of autosomal recessive polycystic kidney disease (ARPKD) during the early second trimester.
    Wisser J; Hebisch G; Froster U; Zerres K; Stallmach T; Leumann E; Schinzel A; Huch A
    Prenat Diagn; 1995 Sep; 15(9):868-71. PubMed ID: 8559760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual sonographic features of ARPKD.
    Okumura M; Bunduki V; Shiang C; Schultz R; Zugaib M
    Prenat Diagn; 2006 Apr; 26(4):330-2. PubMed ID: 16491512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sonographic pattern of recessive polycystic kidney disease in young adults. Differences from the dominant form.
    Nicolau C; Torra R; Badenas C; Pérez L; Oliver JA; Darnell A; Brú C
    Nephrol Dial Transplant; 2000 Sep; 15(9):1373-8. PubMed ID: 10978393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of fetal hyperechogenic cystic kidneys unrelated to renal tract anomalies: A multicenter study.
    Chaumoitre K; Brun M; Cassart M; Maugey-Laulom B; Eurin D; Didier F; Avni EF
    Ultrasound Obstet Gynecol; 2006 Dec; 28(7):911-7. PubMed ID: 17094077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaric aciduria type II: a case report.
    Domizio S; Romanelli A; Brindisino P; Puglielli C; Conte E; Domizio R; Sgarrella MC; Sabatino G
    Int J Immunopathol Pharmacol; 2005; 18(4):805-8. PubMed ID: 16388731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of delivery of a fetus with autosomal recessive polycystic kidney disease: a case report of abdominal dystocia and review of the literature.
    Belin S; Delco C; Parvex P; Hanquinet S; Fokstuen S; Martinez de Tejada B; Eperon I
    J Med Case Rep; 2019 Dec; 13(1):366. PubMed ID: 31829256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal ultrasound in fetuses with polycystic kidney appearance - expanding the diagnostic algorithm.
    Simonini C; Fröschen EM; Nadal J; Strizek B; Berg C; Geipel A; Gembruch U
    Arch Gynecol Obstet; 2023 Oct; 308(4):1287-1300. PubMed ID: 36310336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal polycystic kidney disease associated with glutaric aciduria type II: an inborn error of energy metabolism.
    Whitfield J; Hurst D; Bennett MJ; Sherwood WG; Hogg R; Gonsoulin W
    Am J Perinatol; 1996 Apr; 13(3):131-4. PubMed ID: 8688100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inborn errors of mitochondrial fatty acid oxidation.
    Vianey-Liaud C; Divry P; Gregersen N; Mathieu M
    J Inherit Metab Dis; 1987; 10 Suppl 1():159-200. PubMed ID: 3119938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal recessive polycystic kidney disease: long-term sonographic findings in patients surviving the neonatal period.
    Blickman JG; Bramson RT; Herrin JT
    AJR Am J Roentgenol; 1995 May; 164(5):1247-50. PubMed ID: 7717240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatally diagnosed autosomal recessive polycystic kidney disease: initial postnatal management.
    Munding M; Al-Uzri A; Gralnek D; Riden D
    Urology; 1999 Dec; 54(6):1097. PubMed ID: 10754160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal and infant outcome of fetuses with prenatally diagnosed hyperechogenic kidneys.
    Yulia A; Napolitano R; Aiman A; Desai D; Johal N; Whitten M; Ushakov F; Pandya PP; Winyard PJD
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):953-958. PubMed ID: 32530118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors for Early Dialysis Dependency in Autosomal Recessive Polycystic Kidney Disease.
    Burgmaier K; Kunzmann K; Ariceta G; Bergmann C; Buescher AK; Burgmaier M; Dursun I; Duzova A; Eid L; Erger F; Feldkoetter M; Galiano M; Geßner M; Goebel H; Gokce I; Haffner D; Hooman N; Hoppe B; Jankauskiene A; Klaus G; König J; Litwin M; Massella L; Mekahli D; Melek E; Mir S; Pape L; Prikhodina L; Ranchin B; Schild R; Seeman T; Sever L; Shroff R; Soliman NA; Stabouli S; Stanczyk M; Tabel Y; Taranta-Janusz K; Testa S; Thumfart J; Topaloglu R; Weber LT; Wicher D; Wühl E; Wygoda S; Yilmaz A; Zachwieja K; Zagozdzon I; Zerres K; ; ; Dötsch J; Schaefer F; Liebau MC;
    J Pediatr; 2018 Aug; 199():22-28.e6. PubMed ID: 29753540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Law LK; Tang NL; Hui J; Fung SL; Ruiter J; Wanders RJ; Fok TF; Lam CW
    Clin Chim Acta; 2009 Jun; 404(2):95-9. PubMed ID: 19265687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease.
    Béhin A; Acquaviva-Bourdain C; Souvannanorath S; Streichenberger N; Attarian S; Bassez G; Brivet M; Fouilhoux A; Labarre-Villa A; Laquerrière A; Pérard L; Kaminsky P; Pouget J; Rigal O; Vanhulle C; Eymard B; Vianey-Saban C; Laforêt P
    Rev Neurol (Paris); 2016 Mar; 172(3):231-41. PubMed ID: 27038534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaric acidemia type II: heterogeneity of clinical and biochemical phenotypes.
    Loehr JP; Goodman SI; Frerman FE
    Pediatr Res; 1990 Mar; 27(3):311-5. PubMed ID: 2320399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.